Blockade of VEGF ligand or gene silencing of VEGFR2 appears to inhibit the differentiation of tumor endothelial progenitors into endothelium, but not the differentiation of glioma stem-like cells into immature tumor endothelial progenitors [6]. The gene discussed is KDR; the disease is neoplasm.